Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Solid Tumor 2Osteoporosis 1Lymphatic Metastasis 1Lung Neoplasms 1Immunoglobulin Light-chain Amyloidosis 1Endometrial Neoplasms 1Amyloidosis 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Technetium × Clear all
NCT07146295 2026-01-12

INFINITE

St. Antonius Hospital

Phase NA Recruiting
1,760 enrolled
Breast

Breast Neoplasms, Lymphatic Metastasis

NCT06024213 2024-05-10

OASIS

BTG International Inc.

Completed
101 enrolled
Breast

Breast Neoplasms

NCT02279108 2018-04-09

FLUOTECH

Centre Hospitalier Universitaire de Saint Etienne

Phase 3 Completed
99 enrolled 15 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡